Claraphi Advisory Network’s iShares Biotechnology ETF IBB Stock Holding History

Claraphi Advisory Network’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-343	Closed	-$37K	–	691
2020 Q1	$37K	Buy	+343	New	+$39.5K	0.02%	525
2019 Q4	–	Sell	-330	Closed	-$33K	–	284
2019 Q3	$33K	Buy	+330	New	+$34.5K	0.02%	287

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Claraphi Advisory Network's IBB Position: Q2 2020 in Review

Claraphi Advisory Network sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 343 shares — an estimated $37K sold.

Claraphi Advisory Network first reported a position in IBB in Q3 2019 and held it in 2 quarters. The position peaked at $37K in Q1 2020. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

Claraphi Advisory Network reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
Claraphi Advisory Network sold 343 iShares Biotechnology ETF shares in Q2 2020, an estimated $37K.
Claraphi Advisory Network first reported a position in iShares Biotechnology ETF in Q3 2019 and held it in 2 quarters.
Claraphi Advisory Network's iShares Biotechnology ETF position peaked at $37K in Q1 2020.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.